Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.

The Lancet. Neurology·2026
Same author

Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injury.

Nature communications·2026
Same author

Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis.

Neurology·2026
Same author

Wind-driven seed dispersal differentially promotes seed trapping and retention across alpine plants.

American journal of botany·2026
Same author

Clinical phenotypes of motor neurone disease in a Kenyan hospital-based population.

Frontiers in neurology·2025
Same journal

Improving pain control in diabetic neuropathy.

The Practitioner·2017
Same journal

Tailor management to the patient with fibroids.

The Practitioner·2017
Same journal

Preventing stroke and assessing risk in women.

The Practitioner·2017
Same journal

Depression in adults linked to maltreatment in childhood.

The Practitioner·2017
Same journal

Early referral improves long-term outcomes in rheumatoid arthritis.

The Practitioner·2017
Same journal

Diagnosing and managing mild cognitive impairment.

The Practitioner·2017
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Diagnosing and managing multiple sclerosis.

Thomas M Jenkins1, Alan J Thompson

  • 1UCL Institute of Neurology, Queen Square, London.

The Practitioner
|October 31, 2009
PubMed
Summary
This summary is machine-generated.

Early diagnosis of relapsing remitting multiple sclerosis (RRMS) is crucial for effective management. Understanding MS subtypes and prognostic factors aids in guiding treatment decisions for this complex neurological condition.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multiple Sclerosis (MS) presents in various forms, with relapsing remitting MS (RRMS) being the most common.
  • RRMS can evolve into secondary progressive MS, while primary progressive MS (PPMS) presents with slow deterioration from onset.
  • Accurate diagnosis and prognosis prediction are vital for managing MS progression.

Purpose of the Study:

  • To outline the diagnostic criteria and prognostic indicators for different forms of MS.
  • To discuss the management strategies for RRMS, including pharmacological treatments.
  • To emphasize the importance of early diagnosis and specialist referral for MS patients.

Main Methods:

  • Review of clinical presentation and symptomology of various MS subtypes.
  • Analysis of factors influencing prognosis in MS.
  • Description of diagnostic approaches and referral pathways.
  • Summary of current pharmacological treatments for RRMS.

Main Results:

  • RRMS is characterized by relapses and remissions, often diagnosed in young women, and can evolve over time.
  • Prognostic factors include sex, initial symptoms (optic neuritis, sensory), and relapse interval.
  • PPMS presents with progressive neurological decline without relapses.
  • Beta interferons and glatiramer acetate are mainstays for RRMS, reducing relapse rates by approximately one-third.

Conclusions:

  • Early diagnosis of RRMS is critical for timely intervention and management.
  • Understanding MS subtypes and prognostic factors aids in personalized patient care.
  • Specialist evaluation and referral are essential for accurate MS diagnosis and treatment planning.